Ventricular tachycardia syndromes

Medical Clinics of North America

Volumn 85, Issue 2, 2001, Pages 267-304

  Saliba, Walid I ^b   Natale, Andrea ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CISAPRIDE; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOFETILIDE; ENCAINIDE; ERYTHROMYCIN; FLECAINIDE; KETOCONAZOLE; METOPROLOL; MORACIZINE; PHENOTHIAZINE DERIVATIVE; PROCAINAMIDE; PROPAFENONE; SOTALOL; TERFENADINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMETHOPRIM;

ARRHYTHMOGENESIS; CARDIOVERSION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MORTALITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SUDDEN DEATH; SYNDROME DELINEATION; TREATMENT OUTCOME;

EID: 0035114193     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70316-3     Document Type: Article

References (100)

1. Clinical sustained uniform ventricular tachycardia in hypertrophic cardiomyopathy: Association with left ventricular apical aneurysm
2. Long-term survival in the Antiarrhythmics Versus Implantable Defibrillators (AVID) registry
3. Antiarrhythmics Versus Implantable Defibrillators (AVID) investigators: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
4. Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases
5. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease
6. Catheter ablation of coexistent bundle branch and interfascicular reentrant ventricular tachycardias
7. A randomized trial of propranolol in patients with acute myocardial infarction
8. Prognostic significance of programmed ventricular stimulation in patients surviving complicated acute myocardial infarction: A prospective study
9. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the two years after myocardial infarction
10. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction
11. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass surgery
12. Bundle branch reentrant ventricular tachycardia: Cumulative experience in 48 patients
13. Pre- and postoperative electrophysiological findings in survivors of cardiac arrest and hypertrophic obstructive cardiomyopathy undergoing myectomy
14. Further characterization of the syndrome of right bundle branch block, ST segment elevation, and sudden cardiac death
15. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome: A multicenter report
16. Lack of effect of amiodarone on survival after extensive infarction. Polish Amiodarone Trial
17. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias. Basel Antiarrhythmic Study of Infarct Survival
18. A randomized study of the prevention of sudden death in patients with coronary artery disease
19. Sustained BBR as a mechanism of clinical tachycardia
20. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarizations. CAMIAT
21. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction
22. Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE study)
23. Long term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest
24. Effect of amiodarone on mortality after myocardial infarction: A double-blind, placebo-controlled, pilot study
25. Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin
26. A comparison of enalapril with hydralazineisosorbide dinitrate in the treatment of chronic congestive heart failure
27. Hypertrophic cardiomyopathy: Pathology and pathogenesis
28. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: Electrophysiologic and anatomic correlates
29. Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction
30. Clinical predictors of implantable cardioverter-defibrillator shocks (results of the CASCADE trial)
31. Randomized trial of low-dose amiodarone in severe congestive heart failure
32. Morality and morbidity in patients receiving encainide, flecainide, or placebo
33. Permanent cardiac pacing in patients with the long QT syndrome
34. Cardiac arrhythmias in Chagas' heart disease
35. Amiodarone and sudden death in patients with hypertrophic cardiomyopathy
36. QTU prolongation and polymorphic ventricular tachycardia due to bradycardia-dependent early afterdepolarizations
37. Prognostic determinants in hypertrophic cardiomyopathy: Prognostic evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic and electrophysiological findings
38. Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy
39. A cellular mechanism for the generation of ventricular arrhythmias by acetylstrophanthidin
40. Death from sarcoid heart disease: United Kingdom series 1971-1986: 300 Cases with 138 deaths
41. Sarcoid heart disease
42. Verapamil for the suppression of idiopathic ventricular tachycardia of LBBB-like morphology
43. Comparison of verapamil and diltiazem in the suppression of idiopathic ventricular tachycardia
44. Sudden coronary deaths in the United States, 1980-1985
45. A new noninvasive index to predict sustained ventrlcular tachycardia and sudden death in the first year after myocardial infarction: Based on signal-averaged electrocardiogram, radionuclide ejection fraction, and Holter monitoring
46. Ventricular tachycardia and sudden death in myotonic dystrophy
47. Corticosteroid therapy for ventricular tachycardia in children with silent lymphocytic myocarditis
48. Congenital deaf mutism, functional heart disease with prolongation of the QT interval, and sudden death
49. Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction. EMIAT
50. Mapping and ablation of an underrecogrdzed form of a left bundle inferior axis normal heart ventricular tachycardia originating from the aortic cusp
51. Evaluation and outcome of patients with syncope
52. Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease
53. Time- and frequency-domain analyses of the signal-averaged ECG in patients with arrhythmogenic right ventricular dysplasia
54. Comparative efficacy of sotalol and Class I antiarrhythmic agents in patients with ventricular tachycardia or fibrillation: Results of the Electrophysiology Study Versus Electrocardiographic Monitoring (ESVEM) trial
55. Prediction of serious arrhythrnic events after myocardial infarction: Signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography
56. Catecholaminergic polymorphic ventricular tachycardia in children
57. Mechanism of repetitive monomorphic ventricular tachycardia
58. Phase 2 reentry as a mechanism of initiation of circus movement aminopyridine
59. Right ventricular dysplasia: A report of 24 cases
60. Causes of sudden death in competitive athletes
61. Sudden death in hypertrophic cardiomyopathy: A profile of 78 patients
62. Asymmetry of retrograde conduction and reentry within the His-Purkinje system: A comparative analysis of left and right ventricular stimulation
63. Long term clinical outcome of right bundle branch radiofrequency catheter ablation for treatment of bundle branch reentrant ventricular tachycardia
64. Prognosis after syncope: Impact of left ventricular function
65. Ventricular late potentials in myotonic dystrophy
66. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
67. The long QT syndrome: Prospective longitudinal study of 328 families
68. Risk factors for sudden death after acute myocardial infarction: Two-year follow up
69. Sudden unexplained death syndrome in southeast Asia
70. Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential
71. Sudden death recorded during Holter monitoring
72. Idiopathic sustained left ventricular tachycardia: Clinical and electrophysiologic characteristics
73. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
74. Risk factors of cardiac arrest in arrhythmogenic right ventricular dysplasia
75. Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex Ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function
76. Hypertrophic cardiomyopathy: Role of the implantable cardioverter defibrillator
77. A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43
78. Aritmie cardiache rare delleta pediatrica
79. Effects of tetrodotoxin, lidocaine, verapamil, and AHR-2666f on ouabain-induced delayed afterdepolarizations in canine Purkinje fibers
80. Electrical alternans and vulnerability to ventricular arrhythmias
81. Left cardiac sympathetic denervation in the therapy of congenital LQTS: A worldwide report
82. Long QT syndrome patients with mutations of the SCNA5 and HERG genes have differential responses to Na + channel blockade and to increases in heart rate: Implications for gene-specific therapy
83. Sarcoidosis of the heart
84. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients
85. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia
86. Cellular electrophysiologic characteristics of chronically infarcted myocardium in dogs susceptible to sustained ventricular tachyarrhythmias
87. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction
88. Transcatheter electrical ablation of right bundle branch: A method of treating macroreentrant ventricular tachycardia attributed to BBR
89. Dofetilide: A new class III antiarrhythmic drug which is safe in patients with congestive heart failure
90. The prognostic significance of programmed ventricular stimulation after myocardial infarction: A review
91. Effect of d-sotalol on mortality in patients with LV dysfunction after recent and remote myocardial infarction
92. Positional cloning of a novel potassium channel gene: KVLQT 1 mutations cause cardiac arrhythmias
93. A new farnilial cardiac syndrome in children
94. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease: Results in patients with inducible and noninducible ventricular tachycardia
95. The prevalence and prognostic significance of arrhythmias in Duchenne type muscular dystrophy
96. Beta blockade during and after myocardial infarction: An overview of randomized trials